# Cardihab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardihab-pty

- Industry: Healthcare IT
- Headquarters: Brisbane, Australia
- Website: www.cardihab.com
- Total disclosed funding: $0M
- Latest round: Seed (Feb 1, 2016)
- Investors on record: 2

## About

Cardihab Pty Ltd. is a healthcare technology company focused on providing innovative digital therapeutic solutions for cardiac rehabilitation, enhancing patient engagement and clinical outcomes through personalized and evidence-based programs.Cardihab specializes in digital therapeutic platforms for cardiac rehabilitation. Founded in 2016 and headquartered in Brisbane, Australia, the company has undergone strategic pivots to enhance its service offerings. The founder, Leonore Ryan, has a history in healthcare innovation, while the current CEO is Helen Souris. Cardihab secured USD 1.35 mn in venture funding in September 2017, led by Uniseed, with participation from Artesian and Slingshot Investments. This round represents the total amount raised by the company to date, which includes two reported deals.Cardihab specializes in delivering a digital therapeutic platform dedicated to cardiac rehabilitation, designed to enhance patient engagement and outcomes through innovative technology. Their core product offering includes a user-friendly app accessible on smartphones, tablets, and computers, facilitating cardiac rehabilitation programs that are evidence-based and personalized for users. The platform serves both healthcare providers and patients, with features such as real-time analytics, integrated telehealth capabilities, and a clinician portal that allows healthcare professionals to tailor virtual care plans in accordance with clinical guidelines. The solutions aim to address barriers to traditional, in-clinic rehabilitation, making cardiac care more convenient and accessible, primarily targeting the Australian market, with potential applications in New Zealand and other regions.Cardihab's revenue model is structured around direct partnerships with healthcare providers and institutions, utilizing their digital therapeutic platform for patient care. Transactions typically involve subscription agreements for access to the platform, alongside potential revenue from training and support services offered to clinicians. The pricing structure accommodates various healthcare settings, enabling providers to effectively integrate Cardihab's solutions into their existing patient management workflows. The Cardihab platform is intended for use in both primary care and specialized cardiac rehabilitation environments, contributing to a comprehensive care strategy emphasizing improved patient adherence and health outcomes.Cardihab plans to leverage the recent USD 1.35 mn funding to drive the development of new digital therapeutic products and expand its market presence. The company aims to enhance its platform with additional features and functionalities, targeting a release of these updates by 2018. Additionally, Cardihab is exploring opportunities to enter international markets, focusing on regions that require enhanced cardiac rehabilitation solutions. The capital raised will support the development and marketing efforts necessary for these initiatives.

## Funding rounds

- Seed, Feb 1, 2016, $0M — Artesian, Slingshot Investments

## Investors

- Artesian (https://capitalatlas.ai/funds/artesian) — Seed
- Slingshot Investments — Seed